Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study

著者: J William L Brown, Nick Cunniffe, Ferrán Prados, Baris Kanber, Joanne Jones, Edward Needham, Zoya Georgieva, David Rog, Owen Pearson, James Overell, David MacManus, Rebecca S. Samson, Jonathan Stutters, Charles ffrench‐Constant, Claudia A. M. Gandini Wheeler‐Kingshott, Carla Moran, Paul D. Flynn, Andrew W. Michell, Robin J.M. Franklin, Siddharthan Chandran, Daniel R. Altmann, Declan Chard, Peter Connick, Alasdair Coles - The Lancet 2021 被引用: 95